title: Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
abstract: Hemizygous deletion in the short (p) arm of chromosome 3 is a common finding in non-small cell lung carcinoma (NSCLC) and is postulated to be a crucial early change in lung tumorigenesis. Yet one of the most frequent nuclear abnormalities in both NSCLC and premalignant bronchial epithelium is increase in chromosomal copy number. Deletion and duplication have not been assessed in the same tumor set by both molecular and cytogenetic methods to determine whether allelic loss correlates with chromosomal duplication in the same tumor cell populations. It is also not established what biological mechanisms might lead to allelic deletion and chromosomal duplication. We have investigated changes in the copy number of chromosome 3 in touch preparations of 38 NSCLCs (19 adenocarcinomas and 19 squamous cell carcinomas) using dual-target, dual-color fluorescence in situ hybridization (FISH) assays. Chromosome 3 centromere probe was matched with a 3p14.2 probe [intron 4 of the fragile histidine triad (FHIT) gene] and a 3p21.31 probe (HSemaIV gene). We then correlated FISH results with results of molecular analyses for allelic losses at loci in the regions to which the FISH probes mapped in 20 of these cases. Although various combinations of FISH abnormalities were sometimes detected within the same specimens, individual cases could be classified according to the predominant FISH pattern, usually with one abnormality present in >60% of tumor cells. Chromosomal duplication, indicated by the presence of more than two centromeric signals, was the most frequent abnormality observed by FISH and was accompanied by loss of specific sequences on 3p in approximately one-half of the specimens in which it was observed. The most frequent abnormality observed by molecular analysis was loss of heterozygosity (LOH) in both of the chromosomal regions tested and was demonstrated in 83% of cases with chromosomal duplication. We conclude that LOH may occur in the presence of chromosomal duplication, suggesting that the duplicated chromosome is homozygous. Our findings imply that LOH occurs before chromosomal duplication during lung carcinogenesis.
authors.affiliation: Division of Medical Oncology, University of Colorado Health Sciences Center, Denver 80262, USA.
authors.forename: M
authors.initials: M
authors.lastname: Varella-Garcia
authors.forename: R M
authors.initials: RM
authors.lastname: Gemmill
authors.forename: S H
authors.initials: SH
authors.lastname: Rabenhorst
authors.forename: A
authors.initials: A
authors.lastname: Lotto
authors.forename: H A
authors.initials: HA
authors.lastname: Drabkin
authors.forename: P A
authors.initials: PA
authors.lastname: Archer
authors.forename: W A
authors.initials: WA
authors.lastname: Franklin
mesh_terms: D017766:Acid Anhydride Hydrolases; D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D002893:Chromosomes, Human, Pair 3; D020440:Gene Duplication; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D019656:Loss of Heterozygosity; D008175:Lung Neoplasms / Q000235:genetics*; D009363:Neoplasm Proteins; D011506:Proteins / Q000235:genetics; D000099170:Bis(5'-adenosyl)triphosphatase
chemical_list: D017766:Acid Anhydride Hydrolases; D009363:Neoplasm Proteins; D011506:Proteins; D000099170:Bis(5'-adenosyl)triphosphatase